Lab Manager | Run Your Lab Like a Business

Uniting Researchers and Industry Partners under a Single Research Network

Inaugural program, Collab Network, fuels new collaborations, learning, and future technology development

The Collab Network symbol overlayed on a picture of three researchers in the lab

The IDT Collab Network provides members access to new opportunities to advance their research through the support of IDT’s global network.

by Integrated DNA Technologies
Register for free to listen to this article
Listen with Speechify

CORALVILLE, IA — With a mission to accelerate the pace of genomics, Integrated DNA Technologies (IDT) has launched Collab Network, a first-of-its-kind IDT program aimed at uniting researchers and industry partners under a single, impactful research network to foster learning, collaboration, and future technology development. The Collab Network Program was officially unveiled at the 2023 Advances in Genome Biology and Technology General Meeting taking place February 6 to February 9 in Hollywood, FL.

The IDT Collab Network provides members access to new opportunities to advance their research through the support of IDT’s global network. The program was established to bolster collaborations to drive new discoveries, spotlight research from around the world, drive the development of new products, and invest in the next generation of researchers. Collab Network members—which are comprised of cutting-edge companies focused on next generation sequencing, automation partners, as well as genomics pioneers whose research spans infectious disease, viral surveillance, oncology, rare disease, and more—are not only experts within their own domain but also educators within the research community. Members to date include: Catalytic Data Science, Complete Genomics (a subsidiary of MGI Tech Co., Ltd.), Element Biosciences, Geneseeq Technology, Helix, MLL Munich Leukemia Laboratory, Novogene, Opentrons Robotics, PerkinElmer, Psomagen, Singular Genomics, Sistemas Genomicos, Ultima Genomics, as well as individual collaborators from industry and academia. 

“Now more than ever, collaborating with research partners who are united in a shared mission to accelerate the pace of genomics is becoming increasingly critical to advancing the future of medicine,” said Demaris Mills, president at IDT. “Our current roster of Collab Network members represents some of the industry’s most disruptive companies who are leading the charge in technology and innovation, as well as genomics developers who are well-respected in their areas of research. By combining our technologies and know-how, together we can unlock new scientific discoveries to rapidly transition from bench to breakthrough.” 

To help researchers accelerate scientific discoveries in cancer research, infectious disease, rare disease, and more, IDT delivers proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. Programs like Collab Network are helping to connect researchers with trusted service providers to advance new discoveries, foster case study development, and invest in the next generation of industry leaders. 

IDT seeks to continue expanding its Collab Network with additional researchers and institutions across all application areas. The program will also feature research grant opportunities, with more details announced later this year.